Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets ![]() |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 5,254,029 | $525,402,853.00 | 4.86% |
U.S. Treasury 4.25% 6/30/2029 | Fixed Income | 180,828,000 | $180,008,623.00 | 1.66% |
U.S. Treasury 4.375% 5/15/2034 | Fixed Income | 111,896,000 | $111,939,841.00 | 1.03% |
U.S. Treasury 4.625% 5/15/2044 | Fixed Income | 98,600,000 | $98,411,940.00 | 0.91% |
AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 94,978,000 | $94,736,186.00 | 0.88% |
Pacific Gas and Electric Co. 2.50% 2/1/2031 | Fixed Income | 105,313,000 | $86,864,479.00 | 0.8% |
Bristol-Myers Squibb Co. 5.20% 2/22/2034 | Fixed Income | 77,545,000 | $77,415,888.00 | 0.72% |
Cisco Systems, Inc. 5.05% 2/26/2034 | Fixed Income | 75,498,000 | $75,470,217.00 | 0.7% |
New Economy Assets Phase 1 Issuer, LLC, Series 2021-1, Class A1, 1.91% 10/20/2061 | Fixed Income | 85,198,000 | $76,011,100.00 | 0.7% |
Boeing Co. 2.75% 2/1/2026 | Fixed Income | 78,514,000 | $74,646,479.00 | 0.69% |
JPMorgan Chase & Co. 1.953% 2/4/2032 (USD-SOFR + 1.065% on 2/4/2031) | Fixed Income | 87,838,000 | $71,477,909.00 | 0.66% |
JPMorgan Chase & Co. 5.581% 4/22/2030 (USD-SOFR + 1.16% on 4/22/2029) | Fixed Income | 69,386,000 | $70,501,033.00 | 0.65% |
Pfizer Investment Enterprises Pte., Ltd. 4.75% 5/19/2033 | Fixed Income | 71,606,000 | $69,800,526.00 | 0.65% |
Pfizer Investment Enterprises Pte., Ltd. 5.30% 5/19/2053 | Fixed Income | 71,818,000 | $69,319,811.00 | 0.64% |
Morgan Stanley 5.831% 4/19/2035 (USD-SOFR + 1.58% on 4/19/2034) | Fixed Income | 59,170,000 | $60,676,232.00 | 0.56% |